Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 1390 record(s)

Req # A-2020-000471

Adverse Reaction Report (AER) for botulinum toxin type A. Report number: E2B_03106151.

Organization: Health Canada

6 page(s)
January 2021

Req # A-2020-000480

Adverse Reaction Reports (AERs). Report numbers: E2B_02236077, E2B_02509328, E2B_02123793, E2B_00439222.

Organization: Health Canada

120 page(s)
January 2021

Req # A-2020-000513

Adverse Reaction Reports (AERs) for DOCETAXEL. Report numbers: 735515, 736109, E2B_02874263, E2B_02874284, E2B_02874482, E2B_02874490, E2B_02874501, E2B_02827637, E2B_02874508, E2B_02594947.

Organization: Health Canada

99 page(s)
January 2021

Req # A-2020-000547

Adverse Reaction Reports (AERs). Report numbers: E2B_02620725, E2B_02817496, E2B_02775725, E2B_02160205, E2B_02839703, E2B_01741041, E2B_02197570, E2B_02186547, E2B_02136662, E2B_02547381.

Organization: Health Canada

174 page(s)
January 2021

Req # A-2020-000594

Adverse Reaction Reports (AER) for botulinum toxin. Report number: E2B_03145732.

Organization: Health Canada

7 page(s)
January 2021

Req # A-2020-000624

Adverse Reaction Reports (AERs). Report numbers: E2B_03069863, E2B_03096494.

Organization: Health Canada

28 page(s)
January 2021

Req # A-2020-000632

Adverse Reaction Reports (AERs). Report numbers: E2B_02118066, 000719315, 000719253, E2B_02140181, E2B_02187160, 000720600, E2B_02225222, E2B_02274414, E2B_02275934.

Organization: Health Canada

121 page(s)
January 2021

Req # A-2020-000736

Adverse Reaction Report (AER) for Botulinum toxin. Report number: E2B_03170851.

Organization: Health Canada

20 page(s)
January 2021

Req # A-2020-000646

Adverse Reaction Reports (AERs) for DEXILANT. Report numbers: E2B_03001390, E2B_03007028. ADR for DEXLANSOPRAZOLE: 000737824. ADRs for ENTYVIO: E2B_03031243, E2B_03046110, E2B_03046110, E2B_02992604. ADRs for IXAZOMIB: E2B_03024203, E2B_03038125. ADRs for VEDOLIZUMAB: E2B_03015043, E2B_03015151, E2B_03017623, E2B_03024509, E2B_03029828, E2B_03037893. ADR for ONDANSETRON: E2B_02992226, E2B_02992333. ADRs for PANTOLOC: E2B_02992556, E2B_03032452.

Organization: Health Canada

345 page(s)
January 2021

Req # A-2020-000661

Adverse Reaction Reports (AERs) for ENTYVIO. Report numbers: E2B_03053792, E2B_03060896, E2B_03063086, E2B_03080431, E2B_03081014, E2B_03086213, E2B_03087012, E2B_03106451, E2B_03108406, E2B_03108809, E2B_03111496, E2B_03111502, E2B_03122662, 000908328, E2B_03077868.

Organization: Health Canada

288 page(s)
January 2021
Date modified: